# Protiva Biotherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/protiva-biotherapeutics

- Industry: Biotechnology
- Headquarters: Seattle, US
- Website: www.protivabio.com
- Total disclosed funding: $8.3M
- Latest round: Series D (Jul 5, 2007)
- Investors on record: 4

## About

Protiva Biotherapeutics is a US-based biotechnology company that operates as a developer of nucleic acid based pharmaceutical products.

## Funding rounds

- Series D, Jul 5, 2007, $3.3M — BDC Capital, GrowthWorks Capital, Canadian Medical Discoveries Fund Inc.
- Series C, Jul 13, 2006, $5M — BDC Capital, GrowthWorks Capital, Canadian Medical Discoveries Fund Inc., Kinetic Capital

## Investors

- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Series C, Series D
- GrowthWorks Capital (https://capitalatlas.ai/funds/growthworks-capital) — Series C, Series D
- Canadian Medical Discoveries Fund Inc. — Series C, Series D
- Kinetic Capital — Series C